Rosai-Dorfman Disease
Symptoms, Doctors, Treatments, Advances & More

Save information for later
Sign Up

Learn About Rosai-Dorfman Disease

What is the definition of Rosai-Dorfman Disease?
Rosai-Dorfman disease is a benign disease which is characterized by over-production and accumulation of a specific type of white blood cell (histiocyte) in the lymph nodes of the body, most often those of the neck (cervical). Other lymph node groups may also be involved and, in some cases, abnormal accumulation of histiocytes may occur in other areas of the body (extranodal). The cause of this condition remains unknown, although altered immune responses and infectious agents may play a role.
What are the alternative names for Rosai-Dorfman Disease?
  • Rosai-Dorfman disease
  • RDD
  • Rosaï-Dorfman disease
  • SHML
  • Sinus histiocytosis with massive lymphadenopathy
Who are the top Rosai-Dorfman Disease Local Doctors?
Elite in Rosai-Dorfman Disease
Elite in Rosai-Dorfman Disease
Referral may be required

Rockefeller Outpatient Pavilion

160 E 53rd St, 
New York, NY 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Eli Diamond is an Oncologist practicing medicine in New York, New York. Dr. Diamond is rated as an Elite provider by MediFind in the treatment of Rosai-Dorfman Disease. He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Reticulohistiocytoma, Rosai-Dorfman Disease, Glioblastoma, Astrocytoma, and Awake Craniotomy. Dr. Diamond is currently accepting new patients.

Elite in Rosai-Dorfman Disease
Elite in Rosai-Dorfman Disease
Referral may be required

MN - Cancer Hematology

200 1st St SW, 
Rochester, MN 
Languages Spoken:
English
Accepting New Patients

Jithma Abeykoon is a Hematologist practicing medicine in Rochester, Minnesota. Dr. Abeykoon is rated as an Elite provider by MediFind in the treatment of Rosai-Dorfman Disease. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Reticulohistiocytoma, Histiocytosis, Waldenstrom Macroglobulinemia, Tissue Biopsy, and Bone Marrow Transplant. Dr. Abeykoon is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Rosai-Dorfman Disease
Oncology | Hematology
Elite in Rosai-Dorfman Disease
Oncology | Hematology
Referral may be required

HealthPartners Frauenshuh Cancer Center

3931 Louisiana Ave, 
S Saint Louis Park, MN 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Gordon Ruan is an Oncologist and a Hematologist practicing medicine in S Saint Louis Park, Minnesota. Dr. Ruan is rated as an Elite provider by MediFind in the treatment of Rosai-Dorfman Disease. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Reticulohistiocytoma, Histiocytosis, Rosai-Dorfman Disease, Non-Langerhans-Cell Histiocytosis, and Bone Marrow Aspiration. Dr. Ruan is board certified in American Board Of Internal Medicine-Medical Oncology, American Board Of Internal Medicine-Hematology, and American Board Of Internal Medicine. Dr. Ruan is currently accepting new patients.

What are the latest Rosai-Dorfman Disease Clinical Trials?
Histiocytic Disorder Follow-up Study

Summary: The purpose of the study is to describe the burden of chronic health conditions, psychological dysfunction, chronic pain, healthcare utilization, worse health-related quality of life, overall mortality, and cause-specific mortality among individuals with histiocytic disorders

Match to trials
Find the right clinical trials for you in under a minute
Get started
In-human CXCR4 Imaging of Hematologic and Solid Tumors Using [68Ga]-Pentixafor-PET

Summary: The purpose of this study is to determine the uptake of the imaging agent \[68Ga\]-pentixafor with PET/CT scans in people with monoclonal gammopathy of undetermined significance (MGUS), smoldering multiple myeloma (SMM), and non-Hodgkin lymphoma (NHL), or you have histiocytic neoplasms (Langerhans cell histiocytosis (LCH), Erdheim-Chester disease (ECD) and/or Rosai-Dorfman disease (RDD).

Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center